Docket Room
SB 778·MD·senate

Clinical Research Pharmacies and Clinical Trials - Permits and Ownership

Signed into LawFiled Feb 6, 2026
Sponsor: Feldman
Latest Action

Approved by the Governor - Chapter 206

Apr 11, 2026

Summary

The law authorizes the Maryland Board of Pharmacy to issue permits for pharmacies that operate solely for clinical research. It allows licensed health‑care providers to hold ownership stakes in such pharmacies, provided a pharmacist is on‑site at all times and the provider does not refer patients for remuneration. The measure also removes clinical‑trial activities from the legal definition of practicing medicine, so they are not subject to standard medical licensing rules.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when SB 778 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice